AVEO Oncology
AVEO
#7099
Rank
$0.52 B
Marketcap
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): $94.31 Million USD

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is $94.31 Million USD. In 2021 the company made a revenue of $42.29 Million USD an increase over the revenue in the year 2020 that were of $6.01 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) $94.31 M123%
2021 $42.29 M602.69%
2020 $6.01 M-79.1%
2019 $28.79 M432.35%
2018 $5.4 M-28.63%
2017 $7.57 M201.35%
2016 $2.51 M-86.78%
2015 $19.02 M4.97%
2014 $18.12 M1301.7%
2013 $1.29 M-93.3%
2012 $19.28 M-88.3%
2011 $0.16 B268.94%
2010 $44.68 M115.66%
2009 $20.71 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
$10.06 B 10,572.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$14.24 B 15,005.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$48.03 B 50,827.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$59.41 B 62,898.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$35.97 B 38,037.60%๐Ÿ‡บ๐Ÿ‡ธ USA